<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Trop. Dis.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Tropical Diseases</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Trop. Dis.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2673-7515</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fitd.2025.1730473</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Mini Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The potential of interferon-gamma in the regulation of hTERT expression: insights into telomere dynamics and immune activation in malaria</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Afolabi</surname><given-names>Israel Sunmola</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/487111/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Fiamitia</surname><given-names>Carrin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3199278/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>OBa</surname><given-names>Emmanuel Babatunde</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wakai</surname><given-names>Theophilus Nang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3121915/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Covenant Applied Informatics and Communication-Africa Centre of Excellence (CApIC-ACE)</institution>, <city>Ota</city>,&#xa0;<country country="ne">Nigeria</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Biochemistry, College of Science and Technology (CST), Covenant University</institution>, <city>Ota</city>,&#xa0;<country country="ne">Nigeria</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Computer and Information Sciences, College of Science and Technology (CST), Covenant University</institution>, <city>Ota</city>,&#xa0;<country country="ne">Nigeria</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Carrin Fiamitia, <email xlink:href="mailto:carrin.fiamitiapgs@stu.cu.edu.ng">carrin.fiamitiapgs@stu.cu.edu.ng</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-27">
<day>27</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>6</volume>
<elocation-id>1730473</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Afolabi, Fiamitia, OBa and Wakai.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Afolabi, Fiamitia, OBa and Wakai</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-27">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Malaria remains a significant burden to public health, causing an estimated 282 million new cases in 2024 alone. Recurrent infections and increasing antimalarial resistance contribute to weakening immunity, a process that includes accelerated cellular ageing in immune cells, associated with telomere shortening. Increasing evidence suggests a link between <italic>Plasmodium</italic> infection and accelerated telomere shortening, as well as immune cell senescence. hTERT, a catalytic subunit of human telomerase enzyme is essential for maintaining telomere length (TL) and cellular replicative capacity. Although predominantly inactive in most somatic cells, hTERT appears to be partially reactivated during chronic malaria, contributing to limited restoration of telomere loss. Mechanisms that drive this unprecedented response is yet to be elucidated. Interferon-gamma (IFN-&#x3b3;) is a key mediator of malaria immunity, driving immune activation, lymphocyte proliferation, and parasite clearance. Evidence from other disease contexts, like cancer, where IFN-&#x3b3; signaling has been linked to hTERT regulation, it is plausible to hypothesize that sustained IFN-&#x3b3; activity may influence hTERT expression during malaria infection; however, this remains hypothetical. While cytokines such as interleukin-6 (IL-6) have been suggested to modulate hTERT, the involvement of IFN-&#x3b3; in regulating hTERT in its regulation during malaria has not been experimentally validated. Herein, we review emerging evidence on IFN-&#x3b3;&#x2013;association to immune activation and explores its potential implications for hTERT regulation and telomere dynamics in malaria, a key knowledge gap that is relevant to immune senescence and susceptibility to reinfection.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<graphic xlink:href="fitd-06-1730473-g000.tif" position="anchor">
<alt-text content-type="machine-generated">Flowchart illustrating how malaria influences immune cell aging and death. Malaria increases proinflammatory cytokines (IFN-γ), affecting CDKN2A and hTERT, which impact telomere length. Changes lead to cellular senescence, contributing to aging and death of immune cells.</alt-text>
</graphic>
</fig>
</p>
</abstract>
<kwd-group>
<kwd>chronic inflammation</kwd>
<kwd>human telomerase</kwd>
<kwd>immune senescence</kwd>
<kwd>interferon-gamma (IFN-&#x3b3;)</kwd>
<kwd>malaria</kwd>
<kwd>telomere length</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. The Covenant University Center for Research, Innovation and Discovery (CUCRID) supports this publication through the payment of the article processing charge (APC).</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="67"/>
<page-count count="7"/>
<word-count count="2576"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Major Tropical Diseases</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Malaria is one of the deadliest diseases, caused by the <italic>Plasmodium</italic> parasite and transmitted by the female <italic>Anopheles</italic> mosquito, considered one of the deadliest animals. This parasitic infection, continues to be a major global health challenge contributing to an estimated 282 million cases and over 610,000 deaths in 2024 alone (<xref ref-type="bibr" rid="B1">1</xref>). The parasite-causing malaria has a complex life cycle in two hosts: human and mosquito. The pathophysiology of malaria is directly linked to effects from the host-parasite interactions and the ensuing immune responses (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Several challenges have hampered the successful elimination of this diseases. Drug resistance and recurrent infections due to immune evasion require more efforts to deeper understanding of malarial immunity (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>The pressure of malaria on the host is largely determined by responses orchestrated by immune response cytokines, which are central to controlling the disease pathogenesis. IFN-&#x3b3; stands out as a critical cytokine, playing an indispensable role in activating antigen presenting cells (APCs) and orchestrating parasite elimination (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). However, an imbalanced or excessive IFN-&#x3b3; response has been linked to immunopathologies and chronic inflammatory conditions (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>We recently showed that global research output has been overwhelmingly focused on viral infections like HIV and COVID-19, leaving a significant gap in research on other infections, with malaria research being notably limited and almost neglected, particularly in African contexts (<xref ref-type="bibr" rid="B11">11</xref>). Chronic infections, such as malaria, can accelerate telomere shortening in immune cells, leading to cellular senescence and potentially weakening immune responses over time (<xref ref-type="bibr" rid="B12">12</xref>). This phenomenon has been observed in human cohorts, where acute <italic>P. falciparum</italic> infection results in significant telomere shortening in peripheral blood cells (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>In this review, we examine the intersection of IFN-&#x3b3; signaling and hTERT regulation in malaria and propose potential avenues for further investigation of their prognostic and therapeutic relevance in combating an infection that disproportionately affects vulnerable communities. A deeper understanding of existing evidence may provide a framework for elucidating how sustained immune activation, particularly mediated by IFN-&#x3b3;, influences telomere length dynamics and cellular senescence. These processes may contribute to disease chronicity and increased susceptibility to reinfection, with important implications for the development of novel therapeutic and prognostic strategies.</p>
<sec id="s1_1">
<label>1.1</label>
<title>Overview of malaria pathophysiology and immune activation</title>
<p>The <italic>Plasmodium</italic> parasite undergoes a complex life cycle, involving asexual reproduction in humans and sexual reproduction in mosquitoes. Upon infection, sporozoites rapidly infect hepatocytes, developing into merozoites that subsequently infect red blood cells (RBCs), leading to the symptomatic blood stage of malaria (<xref ref-type="bibr" rid="B2">2</xref>). The host&#x2019;s immune response to malaria involves both innate and adaptive arms. Innate immune responses are rapidly activated upon parasite recognition, often through pathogen-associated molecular patterns (PAMPs) and Toll-like receptors (TLRs). This leads to the release of various cytokines, including IFN-&#x3b3;, and the recruitment of immune cells such as Natural Killer (NK) cells and macrophages (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). NK cells are a significant early source of IFN-&#x3b3; in response to <italic>P. falciparum</italic>-infected erythrocytes (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Adaptive immune responses develop after repeated exposure and involve CD4+ T helper 1 (Th1) cells, B cells, and antibody production (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). IFN-&#x3b3; production by &#x3b1;&#x3b2;T cells, &#x3b3;&#x3b4;T cells, and NK cells is robustly induced and long-lived after <italic>P. falciparum</italic> infection, persisting for at least 14 months (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Prior exposure influences the immune response: while rapid IFN-&#x3b3; production can lead to efficient parasite control, individuals with histories of prior malaria show an inverse relationship between neopterin and IFN-&#x3b3; levels and the number of previous infections, suggesting a dampened IFN-&#x3b3;-mediated T cell-macrophage interaction with repeated exposure (<xref ref-type="bibr" rid="B20">20</xref>).</p>
</sec>
<sec id="s1_2">
<label>1.2</label>
<title>IFN-&#x3b3; plays a dual role in malaria</title>
<p>Interferon-gamma (IFN-&#x3b3;) cytokine plays a central role in host defense against <italic>Plasmodium</italic> parasites, and its activity has been linked to immune cell activation and parasite clearance (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). It is well known for activating macrophages and promoting parasite phagocytosis (<xref ref-type="bibr" rid="B23">23</xref>). For instance, increased IFN-&#x3b3; production is associated with a reduced incidence of clinical malaria episodes (<xref ref-type="bibr" rid="B24">24</xref>). However, excessive or dysregulated IFN-&#x3b3; can contribute to immunopathology, inflammation, and tissue damage (<xref ref-type="bibr" rid="B8">8</xref>). The magnitude and timing of the IFN-&#x3b3; response are critical, as observed in murine models where early IFN-&#x3b3; production distinguishes nonlethal from lethal infections (<xref ref-type="bibr" rid="B25">25</xref>). <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref> illustrates the proposed relationship between IFN-&#x3b3; signaling and hTERT regulation in the context of malaria infection.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The conceptual framework of IFN-&#x3b3;&#x2013;hTERT interactions in malaria.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fitd-06-1730473-g001.tif">
<alt-text content-type="machine-generated">Diagram showing the impact of malaria on cellular processes. Malaria causes increased inflammation and oxidative stress, leading to cytokine release. It affects telomere shortening and the expression of telomerase and CDKN2A, contributing to cellular senescence. IFN-γ interacts with receptors JAK1, JAK2, leading to activation of STAT1. This influences pathways involving SOCS-1, PI3K, AKT, mTOR, p70S6K, and 4EBP-1, impacting gene expression, protein synthesis, and cellular response via primary and secondary responses, including GAS and ISG genes.</alt-text>
</graphic></fig>
<p>As shown in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>, IFN-&#x3b3;&#x2013;mediated immune activation is linked to alterations in hTERT regulation, potentially influencing telomere dynamics and cellular senescence during malaria.</p>
</sec>
<sec id="s1_3">
<label>1.3</label>
<title>Telomere dynamics, hTERT expression, and malaria-driven inflammation</title>
<p>Telomeres are repetitive DNA sequences (TTAGGG) at chromosome ends that protect genomic integrity (<xref ref-type="bibr" rid="B26">26</xref>; <xref ref-type="bibr" rid="B27">27</xref>). Their length dictates cellular replicative capacity; critical shortening triggers cellular senescence or apoptosis (<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>). Telomere shortening occurs through both replicative processes (the end-replication problem) and non-replicative factors like oxidative stress and inflammation as shown in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref> (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>).</p>
</sec>
<sec id="s1_4">
<label>1.4</label>
<title>Regulation of hTERT</title>
<p>The expression of hTERT, the rate-limiting component of telomerase, is tightly regulated at multiple levels, primarily transcriptionally(<xref ref-type="bibr" rid="B27">27</xref>). Key transcription factors involved include activators like c-Myc, Sp1, NF-kB, STAT3, STAT5, and NFAT1, and repressors such as Mad1, E2F1, NFX1-91, WT1, p53, p27KIP1, and p16 (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Alternative splicing and post-translational modifications also modulate hTERT activity (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Telomere length itself provides a feedback mechanism on gene expression through &#x201c;telomere position effects over long distances&#x201d; (TPE-OLD), where long telomeres can repress genes like hTERT, and short telomeres can lead to their activation by altering chromatin structure (<xref ref-type="bibr" rid="B37">37</xref>).</p>
</sec>
<sec id="s1_5">
<label>1.5</label>
<title>Malaria&#x2019;s impact on telomere dynamics</title>
<p>Malaria-driven inflammation, characterized by oxidative stress and cytokine production, directly causes telomere attrition (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Human studies provide compelling evidence: a single acute <italic>P. falciparum</italic> infection leads to significant telomere shortening and decreased telomerase activity in peripheral blood cells within three months, alongside elevated CDKN2A expression (a senescence marker) (<xref ref-type="bibr" rid="B39">39</xref>). Longitudinal data from travelers show that, following successful treatment, telomerase activity can increase, and telomere length can be gradually restored over a year, suggesting a capacity for telomere repair and reversal of cellular aging in single acute episodes (<xref ref-type="bibr" rid="B13">13</xref>). However, this is contrasted by observations in birds where chronic malaria leads to accelerated and systemic telomere shortening across multiple organs (liver, lungs, spleen, heart, kidney, brain) (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>The impact of malaria on TL is different in acute and chronic exposure conditions. Acute malaria infection induces rapid telomere degradation and suppression of telomerase expression, with partial recovery as parasites are cleared (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>In contrast, prolonged exposure to <italic>Plasmodium</italic> infection, prevalent in endemic regions, can lead to cumulative senescence from repeated infections, exacerbating malaria pathogenesis and accelerating telomere shortening (<xref ref-type="bibr" rid="B41">41</xref>). This chronic state can be marked by a progressive decrease or suppression of IFN-&#x3b3;-mediated T cell-macrophage interactions observed with increasing numbers of prior infections (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Malaria impact specific immune cells. In human lymphocytes, telomerase activity is expressed during development, differentiation, and activation (<xref ref-type="bibr" rid="B42">42</xref>). However, malaria-induced telomere shortening could limit the clonal expansion of T cells, NK cells, and &#x3b3;&#x3b4; T cells, ultimately impairing anti-<italic>Plasmodium</italic> responses and contributing to immune senescence (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). This senescence may heighten reinfection risk by diminishing the capacity for effective and sustained adaptive immunity (<xref ref-type="bibr" rid="B45">45</xref>).</p>
<p>Cellular senescence is often accompanied by the Senescence-Associated Secretory Phenotype (SASP), where senescent cells secrete pro-inflammatory cytokines such as IL-6 and TNF-&#x3b1; (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). This perpetuates a vicious cycle where chronic inflammation further drives telomere erosion and accelerates immune aging in malaria (<xref ref-type="bibr" rid="B47">47</xref>).</p>
</sec>
<sec id="s1_6">
<label>1.6</label>
<title>Interplay of IFN-&#x3b3; and hTERT expression</title>
<p>The molecular interplay between IFN-&#x3b3; and hTERT expression is multifaceted, primarily mediated through the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>).</p>
<sec id="s1_6_1">
<label>1.6.1</label>
<title>IFN-&#x3b3; signaling pathway</title>
<p>IFN-&#x3b3; binding to its receptor triggers the activation of JAKs, leading to the phosphorylation of STAT1. Phosphorylated STAT1 dimerizes, translocates to the nucleus, and binds to Gamma-activated Sequences (GAS) elements in the promoters of Interferon-Stimulated Genes (ISGs), thereby inducing their transcription (<xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
<sec id="s1_6_2">
<label>1.6.2</label>
<title>IFN-&#x3b3;&#x2019;s effects on hTERT</title>
<p>IFN-&#x3b3; plays an essential protective immunity against blood-stage malaria (<xref ref-type="bibr" rid="B18">18</xref>). Human data consistently demonstrate a repressive effect of IFN-&#x3b3; on hTERT. IFN-&#x3b3; signaling represses telomerase activity and hTERT transcription, a process mediated by Interferon Regulatory Factor-1 (IRF-1) (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Ectopic expression of IRF-1 significantly attenuates hTERT promoter activity, and conversely, IRF-1-deficient murine fibroblasts exhibit over 15-fold higher hTERT promoter activity (<xref ref-type="bibr" rid="B53">53</xref>). This effect is further propagated by IRF-1&#x2019;s induction of the cell cycle inhibitor p27Kip1, which subsequently downregulates hTERT mRNA and telomerase activity in human cervical cancer (<xref ref-type="bibr" rid="B54">54</xref>). Interferon-inducible IFI16 also negatively regulates hTERT by inhibiting the transcription factor c-Myc, a potent activator of hTERT (<xref ref-type="bibr" rid="B51">51</xref>). In glioblastoma cell lines, IFN-&#x3b3; treatment alone significantly downregulates hTERT mRNA and protein levels and upregulates p21Waf1 and p27Kip1, further supporting its repressive role (<xref ref-type="bibr" rid="B55">55</xref>).</p>
</sec>
<sec id="s1_6_3">
<label>1.6.3</label>
<title>Epigenetic mechanisms</title>
<p>While direct studies linking STAT1-mediated recruitment of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) to hTERT promoter silencing specifically in human malaria are not explicitly detailed in the provided literature, the broader understanding of hTERT regulation highlights the importance of epigenetic control. hTERT promoter activity is influenced by DNA methylation and histone modifications, such as histone acetylation and methylation patterns. For example, telomerase expression correlates with histone H3 and H4 hyperacetylation and H3K4 methylation. Conversely, repressive epigenetic marks like H3K27me3 are associated with silenced hTERT alleles&#xb9;&#xb3;. STAT proteins are known transcriptional regulators, and their interaction with epigenetic machinery represents a plausible, though not yet fully elucidated in malaria, mechanism for hTERT modulation. Recent studies on chronic inflammation and cell cycle regulation continue to explore these intricate connections, suggesting that IFN-&#x3b3;-induced signaling could indirectly influence hTERT through modulation of epigenetic modifiers (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>).</p>
</sec>
<sec id="s1_6_4">
<label>1.6.4</label>
<title>Context-dependent hTERT regulation by IFN-&#x3b3;</title>
<p>The seemingly dual roles of IFN-&#x3b3;&#x2014;repressing hTERT under certain conditions while being integral to immune responses that necessitate cell proliferation (and thus potentially hTERT activity)&#x2014;can be reconciled through context-dependent mechanisms, particularly distinguishing acute versus chronic inflammation (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B49">49</xref>). In acute immune activation, such as during the initial phase of malaria infection, the rapid proliferation of immune cells (T cells, NK cells) requires telomerase activity to maintain telomere length during intense clonal expansion (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Here, factors like Nuclear Factor of Activated T cells (NFAT1), which directly activates hTERT transcription upon lymphocyte activation, might transiently override direct repressive signals (<xref ref-type="bibr" rid="B59">59</xref>). This is supported by the observation that hTERT is expressed soon after lymphocyte activation (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>).</p>
<p>However, sustained, chronic exposure to IFN-&#x3b3;, as observed in prolonged malaria infections, can lead to the repression of hTERT and contribute to immune senescence (<xref ref-type="bibr" rid="B62">62</xref>). This is evident in studies showing that IFN-&#x3b3; downregulates hTERT via IRF-1/IFI16 pathways (<xref ref-type="bibr" rid="B54">54</xref>) and that chronic malaria accelerates telomere degradation (<xref ref-type="bibr" rid="B12">12</xref>). The inverse correlation between neopterin/IFN-&#x3b3; levels and previous malaria infections further supports a dampened IFN-&#x3b3; response in chronic settings (<xref ref-type="bibr" rid="B63">63</xref>). The distinction between avian and human contexts is important; studies on IRF-4 and IRF-8 in avian systems are not directly applicable to human immune senescence in malaria (<xref ref-type="bibr" rid="B49">49</xref>). The primary focus here remains on human-relevant mechanisms and data.</p>
</sec>
<sec id="s1_6_5">
<label>1.6.5</label>
<title>Relevance of IFN-&#x3b3; in immune defense and telomere attrition during malaria to malaria</title>
<p>Elevated IFN-&#x3b3; during malaria infection plays a critical role in host defense. However, the regulatory effects on hTERT expression can exacerbate telomere attrition in immune cells. This creates a delicate balance: while IFN-&#x3b3; is vital for immediate protection and parasite clearance, its sustained presence and the resulting hTERT regulation might drive immune exhaustion and accelerate cellular aging, impacting long-term immunity against <italic>Plasmodium</italic> parasites (<xref ref-type="bibr" rid="B39">39</xref>). Interventions that selectively temper chronic IFN-&#x3b3;-mediated hTERT repression, or enhance repair mechanisms for telomeres, could potentially restore durable immunity and reduce reinfection risk.</p>
</sec>
</sec>
</sec>
<sec id="s2">
<label>2</label>
<title>Clinical relevance and future considerations</title>
<p>The interplay between IFN-&#x3b3; and hTERT in malaria is complex. While IFN-&#x3b3; generally suppresses hTERT expression <italic>in vitro</italic>, its role in the context of malaria-induced immune activation and telomere shortening needs further elucidation. Malaria infection leads to robust immune cell activation, including T cells, which are known to express telomerase transiently upon activation (<xref ref-type="bibr" rid="B38">38</xref>). However, the progressive telomeric loss seen in immune cells during malaria could be exacerbated by high levels of IFN-&#x3b3;, which promotes telomere attrition. CD4+ T cell-derived IFN-&#x3b3; is essential for controlling blood-stage malaria, highlighting the critical, yet potentially double-edged, nature of this cytokine in infection (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>Conversely, the overall immune response during malaria, including IFN-&#x3b3; production, might also influence the longevity and function of immune cells by affecting their telomere dynamics. Asymptomatic <italic>Plasmodium vivax malaria</italic>, for example, is associated with an IFN-&#x3b3;-program on adaptive immunity, suggesting a role for IFN-&#x3b3; in maintaining a controlled immune state that limits parasite growth (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>). However, the rapid establishment of parasite-specific immune regulatory networks after malaria exposure can hinder vaccine efforts (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>). Understanding how IFN-&#x3b3;&#x2013;mediated immune activation intersects with hTERT regulation and telomere dynamics is critical for clarifying malaria pathogenesis, immune durability, and treatment outcomes. Elucidating this relationship may provide novel biomarkers of immune aging and identify therapeutic windows to balance effective parasite control with long-term immune competence, thereby informing vaccine design and host-directed interventions.</p>
<p>Future research should focus on elucidating the precise molecular mechanisms by which IFN-&#x3b3;-induced STAT1 activation influences epigenetic modifiers to regulate hTERT expression in human immune cells during malaria. Longitudinal studies in human malaria cohorts are necessary to track telomere dynamics and hTERT expression in specific immune cell subsets (T cells, NK cells, &#x3b3;&#x3b4; T cells) across acute and chronic infection stages. Such studies would provide critical insights into the context-dependent effects of IFN-&#x3b3; and help identify optimal windows for interventions targeting hTERT regulation to combat immune senescence and enhance long-term protective immunity against adverse effects of malaria.</p>
</sec>
<sec id="s3" sec-type="conclusions">
<label>3</label>
<title>Conclusion</title>
<p>Ultimately, malaria places the immune system in a difficult dilemma: it must fight hard to survive the present infection, even if that fight quietly erodes its future strength. IFN-&#x3b3; stands at the center of this trade-off&#x2014;indispensable for parasite control, yet potentially costly to immune cell longevity through sustained hTERT repression and telomere erosion. Recognizing this tension reframes malaria not only as an infectious disease but also as a driver of immune aging. Addressing it will require strategies that do more than clear parasites; they must also protect the long-term vitality of the immune system. Only by striking this balance can we move toward durable immunity, more effective vaccines, and interventions that safeguard both survival today and immune resilience tomorrow.</p>
</sec>
</body>
<back>
<sec id="s4" sec-type="author-contributions">
<title>Author contributions</title>
<p>IA: Conceptualization, Writing &#x2013; review &amp; editing, Supervision, Validation. CF: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. EO: Writing &#x2013; review &amp; editing. TW: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p></sec>
<sec id="s6" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s7" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><collab>World Health Organization</collab>
</person-group>. <source>World malaria report 2025</source> (<year>2025</year>). Available online at: <uri xlink:href="https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2025">https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2025</uri> (Accessed <date-in-citation content-type="access-date">April 1, 2025</date-in-citation>).
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Cummings</surname> <given-names>RD</given-names></name>
<name><surname>Hokke</surname> <given-names>CH</given-names></name>
<name><surname>Haslam</surname> <given-names>SM</given-names></name>
</person-group>. 
<article-title>FIGURE 43.1</article-title>. In: <source>Life cycle of Plasmodium falciparum</source>. <publisher-loc>Cold Spring Harbor, New York, USA</publisher-loc>: 
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name> (<year>2022</year>). Available online at: <uri xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK579956/figure/CSHLP5087CH43F1/">https://www.ncbi.nlm.nih.gov/books/NBK579956/figure/CSHLP5087CH43F1/</uri>.
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Moxon</surname> <given-names>CA</given-names></name>
<name><surname>Gibbins</surname> <given-names>MP</given-names></name>
<name><surname>McGuinness</surname> <given-names>D</given-names></name>
<name><surname>Milner</surname> <given-names>DA</given-names></name>
<name><surname>Marti</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>New insights into malaria pathogenesis</article-title>. In: 
<person-group person-group-type="editor">
<name><surname>Abbas</surname> <given-names>AK</given-names></name>
<name><surname>Aster</surname> <given-names>JC</given-names></name>
<name><surname>Feany</surname> <given-names>MB</given-names></name>
</person-group>, editors. <source>Annual review of pathology: mechanisms of disease</source>, <publisher-loc>San Mateo, California, USA</publisher-loc> vol. <volume>15</volume> (<year>2020</year>). p. <page-range>315&#x2013;43</page-range>. Annual Reviews. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-pathmechdis-012419-032640</pub-id>, PMID: <pub-id pub-id-type="pmid">31648610</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ashley</surname> <given-names>EA</given-names></name>
<name><surname>Dhorda</surname> <given-names>M</given-names></name>
<name><surname>Fairhurst</surname> <given-names>RM</given-names></name>
<name><surname>Amaratunga</surname> <given-names>C</given-names></name>
<name><surname>Lim</surname> <given-names>P</given-names></name>
<name><surname>Suon</surname> <given-names>S</given-names></name>
<etal/>
</person-group>. 
<article-title>Spread of artemisinin resistance in Plasmodium falciparum malaria</article-title>. <source>N Engl J Med</source>. (<year>2014</year>) <volume>371</volume>:<page-range>411&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMoa1314981</pub-id>, PMID: <pub-id pub-id-type="pmid">25075834</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ezema</surname> <given-names>CA</given-names></name>
<name><surname>Okagu</surname> <given-names>IU</given-names></name>
<name><surname>Ezeorba</surname> <given-names>TPC</given-names></name>
</person-group>. 
<article-title>Escaping the enemy&#x2019;s bullets: An update on how malaria parasites evade host immune response</article-title>. <source>Parasitol Res</source>. (<year>2023</year>) <volume>122</volume>:<page-range>1715&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00436-023-07868-6</pub-id>, PMID: <pub-id pub-id-type="pmid">37219610</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Olasehinde</surname> <given-names>G</given-names></name>
<name><surname>Diji-Geske</surname> <given-names>R</given-names></name>
<name><surname>Fadina</surname> <given-names>I</given-names></name>
<name><surname>Arogundade</surname> <given-names>D</given-names></name>
<name><surname>Darby</surname> <given-names>P</given-names></name>
<name><surname>Adeleke</surname> <given-names>A</given-names></name>
<etal/>
</person-group>. 
<article-title>Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria</article-title>. <source>Infect Drug Resist</source>. (<year>2019</year>) <volume>12</volume>:<page-range>1941&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/IDR.S190386</pub-id>, PMID: <pub-id pub-id-type="pmid">31308714</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Deng</surname> <given-names>S</given-names></name>
<name><surname>Graham</surname> <given-names>ML</given-names></name>
<name><surname>Chen</surname> <given-names>X-M</given-names></name>
</person-group>. 
<article-title>The complexity of interferon signaling in host defense against protozoan parasite infection</article-title>. <source>Pathogens</source>. (<year>2023</year>) <volume>12</volume>:<elocation-id>319</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens12020319</pub-id>, PMID: <pub-id pub-id-type="pmid">36839591</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Obeagu</surname> <given-names>EI</given-names></name>
</person-group>. 
<article-title>Role of cytokines in immunomodulation during malaria clearance</article-title>. <source>Ann Med Surg</source>. (<year>2024</year>) <volume>86</volume>:<fpage>2873</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MS9.0000000000002019</pub-id>, PMID: <pub-id pub-id-type="pmid">38694310</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bae</surname> <given-names>HR</given-names></name>
<name><surname>Shin</surname> <given-names>S-K</given-names></name>
<name><surname>Lee</surname> <given-names>J-Y</given-names></name>
<name><surname>Ko</surname> <given-names>YJ</given-names></name>
<name><surname>Kim</surname> <given-names>S</given-names></name>
<name><surname>Young</surname> <given-names>HA</given-names></name>
<etal/>
</person-group>. 
<article-title>Chronic low-level IFN-&#x3b3; Expression disrupts mitochondrial complex I activity in renal macrophages: an early mechanistic driver of lupus nephritis pathogenesis</article-title>. <source>Int J Mol Sci</source>. (<year>2024</year>) <volume>26</volume>:<elocation-id>63</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms26010063</pub-id>, PMID: <pub-id pub-id-type="pmid">39795922</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bhol</surname> <given-names>NK</given-names></name>
<name><surname>Bhanjadeo</surname> <given-names>MM</given-names></name>
<name><surname>Singh</surname> <given-names>AK</given-names></name>
<name><surname>Dash</surname> <given-names>UC</given-names></name>
<name><surname>Ojha</surname> <given-names>RR</given-names></name>
<name><surname>Majhi</surname> <given-names>S</given-names></name>
<etal/>
</person-group>. 
<article-title>The interplay between cytokines, inflammation, and antioxidants: Mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds</article-title>. <source>Biomed Pharmacother</source>. (<year>2024</year>) <volume>178</volume>:<elocation-id>117177</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2024.117177</pub-id>, PMID: <pub-id pub-id-type="pmid">39053423</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wakai</surname> <given-names>TN</given-names></name>
<name><surname>Yensii</surname> <given-names>NG</given-names></name>
<name><surname>Kernyuy</surname> <given-names>FB</given-names></name>
<name><surname>Bella-Omunagbe</surname> <given-names>M</given-names></name>
<name><surname>Chinedu</surname> <given-names>SN</given-names></name>
<name><surname>Afolabi</surname> <given-names>IS</given-names></name>
</person-group>. 
<article-title>Global research landscape of telomere biology in infectious diseases: mechanistic links between host&#x2013;pathogen interactions and immune ageing</article-title>. <source>Front Aging</source>. (<year>2025</year>) <volume>6</volume>:<elocation-id>1729868</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fragi.2025.1729868</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wakai</surname> <given-names>TN</given-names></name>
<name><surname>Fiamitia</surname> <given-names>C</given-names></name>
<name><surname>Oba</surname> <given-names>EB</given-names></name>
<name><surname>Chinedu</surname> <given-names>SN</given-names></name>
<name><surname>Afolabi</surname> <given-names>IS</given-names></name>
</person-group>. 
<article-title>Malaria infection and telomere length: A review</article-title>. <source>Microbial Pathogen</source>. (<year>2025</year>) <volume>209</volume>:<elocation-id>108072</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2025.108072</pub-id>, PMID: <pub-id pub-id-type="pmid">41072589</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Asghar</surname> <given-names>M</given-names></name>
<name><surname>Yman</surname> <given-names>V</given-names></name>
<name><surname>Homann</surname> <given-names>MV</given-names></name>
<name><surname>Sond&#xe9;n</surname> <given-names>K</given-names></name>
<name><surname>Hammar</surname> <given-names>U</given-names></name>
<name><surname>Hasselquist</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>Cellular aging dynamics after acute malaria infection: A 12-month longitudinal study</article-title>. <source>Aging Cell</source>. (<year>2018</year>) <volume>17</volume>:<elocation-id>e12702</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.12702</pub-id>, PMID: <pub-id pub-id-type="pmid">29143441</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ghosh</surname> <given-names>D</given-names></name>
<name><surname>Stumhofer</surname> <given-names>JS</given-names></name>
</person-group>. 
<article-title>Do you see what I see: Recognition of protozoan parasites by Toll-like receptors</article-title>. <source>Curr Immunol Rev</source>. (<year>2013</year>) <volume>9</volume>:<page-range>129&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1573395509666131203225929</pub-id>, PMID: <pub-id pub-id-type="pmid">25383072</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mogensen</surname> <given-names>TH</given-names></name>
</person-group>. 
<article-title>Pathogen recognition and inflammatory signaling in innate immune defenses</article-title>. <source>Clin Microbiol Rev</source>. (<year>2009</year>) <volume>22</volume>:<page-range>240&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00046-08</pub-id>, PMID: <pub-id pub-id-type="pmid">19366914</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ing</surname> <given-names>R</given-names></name>
<name><surname>Gros</surname> <given-names>P</given-names></name>
<name><surname>Stevenson</surname> <given-names>MM</given-names></name>
</person-group>. 
<article-title>Interleukin-15 enhances innate and adaptive immune responses to blood-stage malaria infection in mice</article-title>. <source>Infect Immun</source>. (<year>2005</year>) <volume>73</volume>:<page-range>3172&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.73.5.3172-3177.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15845528</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weng</surname> <given-names>N</given-names></name>
</person-group>. 
<article-title>Telomere and adaptive immunity</article-title>. <source>Mech Ageing Dev</source>. (<year>2008</year>) <volume>129</volume>:<page-range>60&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mad.2007.11.005</pub-id>, PMID: <pub-id pub-id-type="pmid">18199471</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Inoue</surname> <given-names>S-I</given-names></name>
<name><surname>Niikura</surname> <given-names>M</given-names></name>
<name><surname>Mineo</surname> <given-names>S</given-names></name>
<name><surname>Kobayashi</surname> <given-names>F</given-names></name>
</person-group>. 
<article-title>Roles of IFN-&#x3b3; and &#x3b3;&#x3b4; T cells in protective immunity against blood-stage malaria</article-title>. <source>Front Immunol</source>. (<year>2013</year>) <volume>4</volume>:<elocation-id>258</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2013.00258</pub-id>, PMID: <pub-id pub-id-type="pmid">24009610</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kouriba</surname> <given-names>B</given-names></name>
<name><surname>Daou</surname> <given-names>M</given-names></name>
<name><surname>Arama</surname> <given-names>C</given-names></name>
<name><surname>Ou&#xe9;draogo</surname> <given-names>N</given-names></name>
<name><surname>Niar&#xe9;</surname> <given-names>K</given-names></name>
<name><surname>Keita</surname> <given-names>Y</given-names></name>
<etal/>
</person-group>. 
<article-title>Plasmodium falciparum malaria exposure and carriage associate with reduced &#x3b3;&#x3b4; T-cells and NK cell responses to infected red blood cells <italic>in vitro</italic></article-title>. <source>Arch Microbiol Immunol</source>. (<year>2023</year>) <volume>7</volume>:<page-range>513&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21203/rs.3.rs-2771048/v1</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Soulard</surname> <given-names>V</given-names></name>
<name><surname>Roland</surname> <given-names>J</given-names></name>
<name><surname>Gorgette</surname> <given-names>O</given-names></name>
<name><surname>Barbier</surname> <given-names>E</given-names></name>
<name><surname>Cazenave</surname> <given-names>P-A</given-names></name>
<name><surname>Pied</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>An early burst of IFN-&#x3b3; induced by the pre-erythrocytic stage favours Plasmodium yoelii parasitaemia in B6 mice</article-title>. <source>Malaria J</source>. (<year>2009</year>) <volume>8</volume>:<elocation-id>128</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1475-2875-8-128</pub-id>, PMID: <pub-id pub-id-type="pmid">19508725</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Artavanis-Tsakonas</surname> <given-names>K</given-names></name>
<name><surname>Riley</surname> <given-names>EM</given-names></name>
</person-group>. 
<article-title>Innate immune response to malaria: rapid induction of IFN-&#x3b3; from human NK cells by live plasmodium falciparum-infected erythrocytes1</article-title>. <source>J Immunol</source>. (<year>2002</year>) <volume>169</volume>:<page-range>2956&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.169.6.2956</pub-id>, PMID: <pub-id pub-id-type="pmid">12218109</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mahittikorn</surname> <given-names>A</given-names></name>
<name><surname>Mala</surname> <given-names>W</given-names></name>
<name><surname>Masangkay</surname> <given-names>FR</given-names></name>
<name><surname>Kotepui</surname> <given-names>KU</given-names></name>
<name><surname>Wilairatana</surname> <given-names>P</given-names></name>
<name><surname>Kotepui</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Increased interferon-&#x3b3; levels and risk of severe malaria: A meta-analysis</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>18917</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-21965-z</pub-id>, PMID: <pub-id pub-id-type="pmid">36344583</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>King</surname> <given-names>T</given-names></name>
<name><surname>Lamb</surname> <given-names>T</given-names></name>
</person-group>. 
<article-title>Interferon-&#x3b3;: the jekyll and hyde of malaria</article-title>. <source>PLoS Pathog</source>. (<year>2015</year>) <volume>11</volume>:<elocation-id>e1005118</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1005118</pub-id>, PMID: <pub-id pub-id-type="pmid">26426121</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Popa</surname> <given-names>GL</given-names></name>
<name><surname>Popa</surname> <given-names>MI</given-names></name>
</person-group>. 
<article-title>Recent advances in understanding the inflammatory response in malaria: A review of the dual role of cytokines</article-title>. <source>J Immunol Res</source>. (<year>2021</year>) <volume>2021</volume>:<elocation-id>7785180</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2021/7785180</pub-id>, PMID: <pub-id pub-id-type="pmid">34790829</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De Souza</surname> <given-names>JB</given-names></name>
<name><surname>Williamson</surname> <given-names>KH</given-names></name>
<name><surname>Otani</surname> <given-names>T</given-names></name>
<name><surname>Playfair</surname> <given-names>JH</given-names></name>
</person-group>. 
<article-title>Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria</article-title>. <source>Infect Immun</source>. (<year>1997</year>) <volume>65</volume>:<page-range>1593&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.65.5.1593-1598.1997</pub-id>, PMID: <pub-id pub-id-type="pmid">9125535</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chakravarti</surname> <given-names>D</given-names></name>
<name><surname>LaBella</surname> <given-names>KA</given-names></name>
<name><surname>DePinho</surname> <given-names>RA</given-names></name>
</person-group>. 
<article-title>Telomeres: History, health, and hallmarks of aging</article-title>. <source>Cell</source>. (<year>2021</year>) <volume>184</volume>:<page-range>306&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2020.12.028</pub-id>, PMID: <pub-id pub-id-type="pmid">33450206</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Lee</surname> <given-names>J</given-names></name>
<name><surname>Pellegrini</surname> <given-names>MV</given-names></name>
</person-group>. 
<article-title>Biochemistry, telomere and telomerase</article-title>. In: <source>StatPearls</source>. <publisher-loc>Treasure Island, Florida, USA</publisher-loc>: 
<publisher-name>StatPearls Publishing</publisher-name> (<year>2023</year>). Available online at: <uri xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK576429/">http://www.ncbi.nlm.nih.gov/books/NBK576429/</uri>.
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bernadotte</surname> <given-names>A</given-names></name>
<name><surname>Mikhelson</surname> <given-names>VM</given-names></name>
<name><surname>Spivak</surname> <given-names>IM</given-names></name>
</person-group>. 
<article-title>Markers of cellular senescence. Telomere shortening as a marker of cellular senescence</article-title>. <source>Aging</source>. (<year>2016</year>) <volume>8</volume>:<fpage>3</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/aging.100871</pub-id>, PMID: <pub-id pub-id-type="pmid">26805432</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ci</surname> <given-names>X</given-names></name>
<name><surname>Li</surname> <given-names>B</given-names></name>
<name><surname>Ma</surname> <given-names>X</given-names></name>
<name><surname>Kong</surname> <given-names>F</given-names></name>
<name><surname>Zheng</surname> <given-names>C</given-names></name>
<name><surname>Bj&#xf6;rkholm</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of Malignant cells</article-title>. <source>Oncotarget</source>. (<year>2015</year>) <volume>6</volume>:<page-range>38079&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.5752</pub-id>, PMID: <pub-id pub-id-type="pmid">26472030</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fathi</surname> <given-names>E</given-names></name>
<name><surname>Charoudeh</surname> <given-names>HN</given-names></name>
<name><surname>Sanaat</surname> <given-names>Z</given-names></name>
<name><surname>Farahzadi</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Telomere shortening as a hallmark of stem cell senescence</article-title>. <source>Stem Cell Invest</source>. (<year>2019</year>) <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/sci.2019.02.04</pub-id>. Article 0., PMID: <pub-id pub-id-type="pmid">31019963</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Armstrong</surname> <given-names>E</given-names></name>
<name><surname>Boonekamp</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Does oxidative stress shorten telomeres <italic>in vivo</italic>? A meta-analysis</article-title>. <source>Ageing Res Rev</source>. (<year>2023</year>) <volume>85</volume>:<elocation-id>101854</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.arr.2023.101854</pub-id>, PMID: <pub-id pub-id-type="pmid">36657619</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Stewart</surname> <given-names>JA</given-names></name>
<name><surname>Chaiken</surname> <given-names>MF</given-names></name>
<name><surname>Wang</surname> <given-names>F</given-names></name>
<name><surname>Price</surname> <given-names>CM</given-names></name>
</person-group>. 
<article-title>Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation</article-title>. <source>Mutat Res</source>. (<year>2012</year>) <volume>730</volume>:<page-range>12&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrfmmm.2011.08.011</pub-id>, PMID: <pub-id pub-id-type="pmid">21945241</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Khattar</surname> <given-names>E</given-names></name>
<name><surname>Tergaonkar</surname> <given-names>V</given-names></name>
</person-group>. 
<article-title>Transcriptional regulation of telomerase reverse transcriptase (TERT) by MYC</article-title>. <source>Front Cell Dev Biol</source>. (<year>2017</year>) <volume>5</volume>:<elocation-id>1</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2017.00001</pub-id>, PMID: <pub-id pub-id-type="pmid">28184371</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Le&#xe3;o</surname> <given-names>R</given-names></name>
<name><surname>Apol&#xf3;nio</surname> <given-names>JD</given-names></name>
<name><surname>Lee</surname> <given-names>D</given-names></name>
<name><surname>Figueiredo</surname> <given-names>A</given-names></name>
<name><surname>Tabori</surname> <given-names>U</given-names></name>
<name><surname>Castelo-Branco</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: Clinical impacts in cancer</article-title>. <source>J Biomed Sci</source>. (<year>2018</year>) <volume>25</volume>:<elocation-id>22</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12929-018-0422-8</pub-id>, PMID: <pub-id pub-id-type="pmid">29526163</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Plyasova</surname> <given-names>AA</given-names></name>
<name><surname>Zhdanov</surname> <given-names>DD</given-names></name>
</person-group>. 
<article-title>Alternative splicing of human telomerase reverse transcriptase (hTERT) and its implications in physiological and pathological processes</article-title>. <source>Biomedicines</source>. (<year>2021</year>) <volume>9</volume>:<elocation-id>526</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biomedicines9050526</pub-id>, PMID: <pub-id pub-id-type="pmid">34065134</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shepelev</surname> <given-names>N</given-names></name>
<name><surname>Dontsova</surname> <given-names>O</given-names></name>
<name><surname>Rubtsova</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Post-transcriptional and post-translational modifications in telomerase biogenesis and recruitment to telomeres</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>:<elocation-id>5027</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24055027</pub-id>, PMID: <pub-id pub-id-type="pmid">36902458</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname> <given-names>W</given-names></name>
<name><surname>Shay</surname> <given-names>JW</given-names></name>
</person-group>. 
<article-title>Long-range telomere regulation of gene expression: telomere looping and telomere position effect over long distances (TPE-OLD)</article-title>. <source>Differ Res Biol Diversity</source>. (<year>2018</year>) <volume>99</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.diff.2017.11.005</pub-id>, PMID: <pub-id pub-id-type="pmid">29197683</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Miglar</surname> <given-names>A</given-names></name>
<name><surname>Reuling</surname> <given-names>I</given-names></name>
<name><surname>Yap</surname> <given-names>XZ</given-names></name>
<name><surname>F&#xe4;rnert</surname> <given-names>A</given-names></name>
<name><surname>Sauerwein</surname> <given-names>R</given-names></name>
<name><surname>Asghar</surname> <given-names>M</given-names></name>
</person-group>. <source>An interplay between inflammation, oxidative stress and cellular aging in a controlled human malaria challenge study</source>. (<year>2020</year>), <publisher-loc>New York</publisher-loc>: 
<publisher-name>SSRN</publisher-name>, SSRN Scholarly Paper No. 3565022. doi:&#xa0;<pub-id pub-id-type="doi">10.2139/ssrn.3565022</pub-id>.
</mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Miglar</surname> <given-names>A</given-names></name>
</person-group>. <source>The effect of Plasmodium infection on cellular aging in humans</source>. <publisher-loc>Solna</publisher-loc>: 
<publisher-name>Inst f&#xf6;r medicin, Solna/Dept of Medicine</publisher-name> (<year>2023</year>). Available online at: <uri xlink:href="https://openarchive.ki.se/articles/thesis/The_effect_of_Plasmodium_infection_on_cellular_aging_in_humans/26903185">https://openarchive.ki.se/articles/thesis/The_effect_of_Plasmodium_infection_on_cellular_aging_in_humans/26903185</uri> (Accessed <date-in-citation content-type="access-date">April 1, 2025</date-in-citation>).
</mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Asghar</surname> <given-names>M</given-names></name>
<name><surname>Palinauskas</surname> <given-names>V</given-names></name>
<name><surname>Zaghdoudi-Allan</surname> <given-names>N</given-names></name>
<name><surname>Valki&#x16b;nas</surname> <given-names>G</given-names></name>
<name><surname>Mukhin</surname> <given-names>A</given-names></name>
<name><surname>Platonova</surname> <given-names>E</given-names></name>
<etal/>
</person-group>. 
<article-title>Parallel telomere shortening in multiple body tissues owing to malaria infection</article-title>. <source>Proc R Soc B: Biol Sci</source>. (<year>2016</year>) <volume>283</volume>:<elocation-id>20161184</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rspb.2016.1184</pub-id>, PMID: <pub-id pub-id-type="pmid">27488651</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Band</surname> <given-names>G</given-names></name>
<name><surname>Leffler</surname> <given-names>EM</given-names></name>
</person-group>. 
<article-title>Malaria endemicity linked to shorter telomeres in leukocytes</article-title>. <source>Trends Parasitol</source>. (<year>2024</year>) <volume>40</volume>:<page-range>660&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2024.06.017</pub-id>, PMID: <pub-id pub-id-type="pmid">39013662</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Akbar</surname> <given-names>AN</given-names></name>
<name><surname>Vukmanovic-Stejic</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Telomerase in T lymphocytes: Use it and lose it</article-title>? <source>J Immunol (Baltimore Md: 1950)</source>. (<year>2007</year>) <volume>178</volume>:<page-range>6689&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6689</pub-id>, PMID: <pub-id pub-id-type="pmid">17513711</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Anzaku</surname> <given-names>DO</given-names></name>
<name><surname>Afolabi</surname> <given-names>IS</given-names></name>
</person-group>. 
<article-title>Critical understanding of the influence of cellular aging biomarkers on host&#x2013;parasite relationships serving as a key platform for malaria eradication</article-title>. <source>Biology</source>. (<year>2025</year>) <volume>14</volume>:<elocation-id>1458</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biology14101458</pub-id>, PMID: <pub-id pub-id-type="pmid">41154861</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ho</surname> <given-names>M</given-names></name>
<name><surname>Tongtawe</surname> <given-names>P</given-names></name>
<name><surname>Kriangkum</surname> <given-names>J</given-names></name>
<name><surname>Wimonwattrawatee</surname> <given-names>T</given-names></name>
<name><surname>Pattanapanyasat</surname> <given-names>K</given-names></name>
<name><surname>Bryant</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria</article-title>. <source>Infect Immun</source>. (<year>1994</year>) <volume>62</volume>:<page-range>855&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.62.3.855-862.1994</pub-id>, PMID: <pub-id pub-id-type="pmid">8112855</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Marrella</surname> <given-names>V</given-names></name>
<name><surname>Facoetti</surname> <given-names>A</given-names></name>
<name><surname>Cassani</surname> <given-names>B</given-names></name>
</person-group>. 
<article-title>Cellular senescence in immunity against infections</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>11845</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms231911845</pub-id>, PMID: <pub-id pub-id-type="pmid">36233146</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kumari</surname> <given-names>R</given-names></name>
<name><surname>Jat</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype</article-title>. <source>Front Cell Dev Biol</source>. (<year>2021</year>) <volume>9</volume>:<elocation-id>645593</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2021.645593</pub-id>, PMID: <pub-id pub-id-type="pmid">33855023</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Baechle</surname> <given-names>JJ</given-names></name>
<name><surname>Chen</surname> <given-names>N</given-names></name>
<name><surname>Makhijani</surname> <given-names>P</given-names></name>
<name><surname>Winer</surname> <given-names>S</given-names></name>
<name><surname>Furman</surname> <given-names>D</given-names></name>
<name><surname>Winer</surname> <given-names>DA</given-names></name>
</person-group>. 
<article-title>Chronic inflammation and the hallmarks of aging</article-title>. <source>Mol Metab</source>. (<year>2023</year>) <volume>74</volume>:<elocation-id>101755</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molmet.2023.101755</pub-id>, PMID: <pub-id pub-id-type="pmid">37329949</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Horvath</surname> <given-names>CM</given-names></name>
</person-group>. 
<article-title>The Jak-STAT pathway stimulated by interferon gamma</article-title>. <source>Sci&#x2019;s STKE: Signal Transduction Knowl Environ</source>. (<year>2004</year>) <volume>2004</volume>:<elocation-id>tr8</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/stke.2602004tr8</pub-id>, PMID: <pub-id pub-id-type="pmid">15561980</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>L</given-names></name>
<name><surname>Zhu</surname> <given-names>Y</given-names></name>
<name><surname>Zhang</surname> <given-names>N</given-names></name>
<name><surname>Xian</surname> <given-names>Y</given-names></name>
<name><surname>Tang</surname> <given-names>Y</given-names></name>
<name><surname>Ye</surname> <given-names>J</given-names></name>
<etal/>
</person-group>. 
<article-title>The multiple roles of interferon regulatory factor family in health and disease</article-title>. <source>Signal Transduction Targeted Ther</source>. (<year>2024</year>) <volume>9</volume>:<fpage>282</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-024-01980-4</pub-id>, PMID: <pub-id pub-id-type="pmid">39384770</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bhat</surname> <given-names>MY</given-names></name>
<name><surname>Solanki</surname> <given-names>HS</given-names></name>
<name><surname>Advani</surname> <given-names>J</given-names></name>
<name><surname>Khan</surname> <given-names>AA</given-names></name>
<name><surname>Keshava Prasad</surname> <given-names>TS</given-names></name>
<name><surname>Gowda</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Comprehensive network map of interferon gamma signaling</article-title>. <source>J Cell Commun Signaling</source>. (<year>2018</year>) <volume>12</volume>:<page-range>745&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12079-018-0486-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30191398</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname> <given-names>LL</given-names></name>
<name><surname>Ponomareva</surname> <given-names>L</given-names></name>
<name><surname>Shen</surname> <given-names>H</given-names></name>
<name><surname>Duan</surname> <given-names>X</given-names></name>
<name><surname>Alimirah</surname> <given-names>F</given-names></name>
<name><surname>Choubey</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene</article-title>. <source>PLoS One</source>. (<year>2010</year>) <volume>5</volume>:<elocation-id>e8569</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0008569</pub-id>, PMID: <pub-id pub-id-type="pmid">20052289</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname> <given-names>D</given-names></name>
<name><surname>Erickson</surname> <given-names>S</given-names></name>
<name><surname>Szeps</surname> <given-names>M</given-names></name>
<name><surname>Gruber</surname> <given-names>A</given-names></name>
<name><surname>Sangfelt</surname> <given-names>O</given-names></name>
<name><surname>Einhorn</surname> <given-names>S</given-names></name>
<etal/>
</person-group>. 
<article-title>Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human Malignant and nonmalignant hematopoietic cells</article-title>. <source>Blood</source>. (<year>2000</year>) <volume>96</volume>:<page-range>4313&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V96.13.4313</pub-id>, PMID: <pub-id pub-id-type="pmid">11110707</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>S</given-names></name>
<name><surname>Liu</surname> <given-names>Z</given-names></name>
<name><surname>Ye</surname> <given-names>Y</given-names></name>
<name><surname>Li</surname> <given-names>B</given-names></name>
<name><surname>Liu</surname> <given-names>T</given-names></name>
<name><surname>Zhang</surname> <given-names>W</given-names></name>
<etal/>
</person-group>. 
<article-title>Ectopic hTERT expression facilitates reprograming of fibroblasts derived from patients with Werner syndrome as a WS cellular model</article-title>. <source>Cell Death Dis</source>. (<year>2018</year>) <volume>9</volume>:<fpage>923</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-018-0948-4</pub-id>, PMID: <pub-id pub-id-type="pmid">30206203</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname> <given-names>S-H</given-names></name>
<name><surname>Kim</surname> <given-names>J-W</given-names></name>
<name><surname>Oh</surname> <given-names>S-H</given-names></name>
<name><surname>Kim</surname> <given-names>Y-J</given-names></name>
<name><surname>Rho</surname> <given-names>S-B</given-names></name>
<name><surname>Park</surname> <given-names>K</given-names></name>
<etal/>
</person-group>. 
<article-title>IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer</article-title>. <source>FEBS Lett</source>. (<year>2005</year>) <volume>579</volume>:<page-range>1027&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.febslet.2005.01.005</pub-id>, PMID: <pub-id pub-id-type="pmid">15710386</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>George</surname> <given-names>J</given-names></name>
<name><surname>Banik</surname> <given-names>NL</given-names></name>
<name><surname>Ray</surname> <given-names>SK</given-names></name>
</person-group>. 
<article-title>Combination of hTERT knockdown and IFN-&#x3b3; Treatment inhibited angiogenesis and tumor progression in glioblastoma</article-title>. <source>Clin Cancer Res</source>. (<year>2009</year>) <volume>15</volume>:<page-range>7186&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-09-1425</pub-id>, PMID: <pub-id pub-id-type="pmid">19934306</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Santourlidis</surname> <given-names>S</given-names></name>
<name><surname>Ara&#xfa;zo-Bravo</surname> <given-names>MJ</given-names></name>
<name><surname>Brodell</surname> <given-names>RT</given-names></name>
<name><surname>Hassan</surname> <given-names>M</given-names></name>
<name><surname>Bendhack</surname> <given-names>ML</given-names></name>
</person-group>. 
<article-title>hTERT epigenetics provides new perspectives for diagnosis and evidence-based guidance of chemotherapy in cancer</article-title>. <source>Int J Mol Sci</source>. (<year>2024</year>) <volume>25</volume>:<elocation-id>7331</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms25137331</pub-id>, PMID: <pub-id pub-id-type="pmid">39000438</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhu</surname> <given-names>J</given-names></name>
<name><surname>Zhao</surname> <given-names>Y</given-names></name>
<name><surname>Wang</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene</article-title>. <source>Protein Cell</source>. (<year>2010</year>) <volume>1</volume>:<fpage>22</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13238-010-0014-1</pub-id>, PMID: <pub-id pub-id-type="pmid">21203995</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Afolabi</surname> <given-names>IS</given-names></name>
<name><surname>Fiamitia</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Interleukin-6-mediated inflammation on telomere length dynamics in malaria infection</article-title>. <source>NIPES JSTR Special Issue</source>. (<year>2025</year>) <volume>7</volume>:<page-range>2579&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.37933/nipes/7.4.2025.SI305</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname> <given-names>J-U</given-names></name>
<name><surname>Kim</surname> <given-names>L-K</given-names></name>
<name><surname>Choi</surname> <given-names>J-M</given-names></name>
</person-group>. 
<article-title>Revisiting the concept of targeting NFAT to control T cell immunity and autoimmune diseases</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>2747</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02747</pub-id>, PMID: <pub-id pub-id-type="pmid">30538703</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chebel</surname> <given-names>A</given-names></name>
<name><surname>Rouault</surname> <given-names>J-P</given-names></name>
<name><surname>Urbanowicz</surname> <given-names>I</given-names></name>
<name><surname>Baseggio</surname> <given-names>L</given-names></name>
<name><surname>Chien</surname> <given-names>W-W</given-names></name>
<name><surname>Salles</surname> <given-names>G</given-names></name>
<etal/>
</person-group>. 
<article-title>Transcriptional activation of hTERT, the human telomerase reverse transcriptase, by nuclear factor of activated T cells</article-title>. <source>J Biol Chem</source>. (<year>2009</year>) <volume>284</volume>:<page-range>35725&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M109.009183</pub-id>, PMID: <pub-id pub-id-type="pmid">19843528</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Patrick</surname> <given-names>M</given-names></name>
<name><surname>Weng</surname> <given-names>N</given-names></name>
</person-group>. 
<article-title>Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases</article-title>. <source>Cell Immunol</source>. (<year>2019</year>) <volume>345</volume>:<elocation-id>103989</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cellimm.2019.103989</pub-id>, PMID: <pub-id pub-id-type="pmid">31558266</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mitchell</surname> <given-names>RA</given-names></name>
<name><surname>Ubillos</surname> <given-names>I</given-names></name>
<name><surname>Requena</surname> <given-names>P</given-names></name>
<name><surname>Campo</surname> <given-names>JJ</given-names></name>
<name><surname>Ome-Kaius</surname> <given-names>M</given-names></name>
<name><surname>Hanieh</surname> <given-names>S</given-names></name>
<etal/>
</person-group>. 
<article-title>Chronic malaria exposure is associated with inhibitory markers on T cells that correlate with atypical memory and marginal zone-like B cells</article-title>. <source>Clin Exp Immunol</source>. (<year>2024</year>) <volume>216</volume>:<page-range>172&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cei/uxae015</pub-id>, PMID: <pub-id pub-id-type="pmid">38387476</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Blankson</surname> <given-names>SO</given-names></name>
<name><surname>Rietmeyer</surname> <given-names>L</given-names></name>
<name><surname>Tettey</surname> <given-names>P</given-names></name>
<name><surname>Dikroh</surname> <given-names>L</given-names></name>
<name><surname>Tornyigah</surname> <given-names>B</given-names></name>
<name><surname>Adamou</surname> <given-names>R</given-names></name>
<etal/>
</person-group>. 
<article-title>High plasma levels of neopterin are associated with increased mortality among children with severe malaria in Benin</article-title>. <source>Diagnostics</source>. (<year>2023</year>) <volume>13</volume>:<elocation-id>528</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/diagnostics13030528</pub-id>, PMID: <pub-id pub-id-type="pmid">36766633</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida</surname> <given-names>GG</given-names></name>
<name><surname>Costa</surname> <given-names>CM</given-names></name>
<name><surname>Costa</surname> <given-names>PAC</given-names></name>
<name><surname>Gomes</surname> <given-names>GR</given-names></name>
<name><surname>Figueiredo</surname> <given-names>MM</given-names></name>
<name><surname>Torres</surname> <given-names>KJ</given-names></name>
<etal/>
</person-group>. 
<article-title>Asymptomatic vivax malaria is associated with an IFN-&#x3b3;-program on adaptive immunity</article-title>. <source>J Trans Med</source>. (<year>2025</year>) <volume>23</volume>:<fpage>351</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-025-06353-1</pub-id>, PMID: <pub-id pub-id-type="pmid">40108661</pub-id>
</mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname> <given-names>RO dos</given-names></name>
<name><surname>Cruz</surname> <given-names>MGS da</given-names></name>
<name><surname>Lopes</surname> <given-names>SCP</given-names></name>
<name><surname>Oliveira</surname> <given-names>LB</given-names></name>
<name><surname>Nogueira</surname> <given-names>PA</given-names></name>
<name><surname>Lima</surname> <given-names>ES</given-names></name>
<etal/>
</person-group>. 
<article-title>A first plasmodium vivax natural infection induces increased activity of the interferon gamma-driven tryptophan catabolism pathway</article-title>. <source>Front Microbiol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>400</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2020.00400</pub-id>, PMID: <pub-id pub-id-type="pmid">32256470</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Boyle</surname> <given-names>MJ</given-names></name>
<name><surname>Engwerda</surname> <given-names>CR</given-names></name>
<name><surname>Jagannathan</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria</article-title>. <source>Nat Rev Immunol</source>. (<year>2024</year>) <volume>24</volume>:<page-range>637&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-024-01041-5</pub-id>, PMID: <pub-id pub-id-type="pmid">38862638</pub-id>
</mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>Y</given-names></name>
<name><surname>De Labastida Rivera</surname> <given-names>F</given-names></name>
<name><surname>Edwards</surname> <given-names>CL</given-names></name>
<name><surname>Frame</surname> <given-names>TCM</given-names></name>
<name><surname>Engel</surname> <given-names>JA</given-names></name>
<name><surname>Bukali</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>STING activation promotes autologous type I interferon&#x2013;dependent development of type 1 regulatory T cells during malaria</article-title>. <source>J Clin Invest</source>. (<year>n.</year>) <volume>133</volume>:<elocation-id>e169417</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI169417</pub-id>, PMID: <pub-id pub-id-type="pmid">37781920</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/714940">Jacy Gameiro</ext-link>, Juiz de Fora Federal University, Brazil</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/867106">Chris Marco Mbianda Nana</ext-link>, University of Yaounde I, Cameroon</p></fn>
</fn-group>
</back>
</article>